With the “Healthy China 2030” Blueprint Guide released in 2016, China has made developing its healthcare sector a national priority. The healthcare industry is expected to surge both in healthcare products and services, thanks to the Central Government’s support, rising individual wealth and an ageing population.
Neighboring Shenzhen, an area packed with companies devoted to healthcare innovation and technology, is poised to provide you with the best up-to-date intelligence into the industry. What are the new trends emerging in the healthTech sector across the border that you cannot offer to miss? How can these developments translate into business opportunities for multinationals?
Please join AmCham HK’s one-day Shenzhen tour to visit several Chinese HealthTech firms. Led by AmCham President Tara Joseph, the delegation will visit the following companies:
Shenzhen HarMoniCare Women & Children's Hospital – it adopts and advocates an American patient safety and care system, which is the world’s leading model of medical technology and management, providing safe and green care for customers
BGI (華大基因) - a leading global genomics organization headquartered in Shenzhen
The China National GeneBank (國家基因庫) – China's first national gene bank, established by BGI, claiming to be the largest of its kind in the world
*A minimum of 15 people is needed to form the delegation. Please do not make any travel arrangement until there is a confirmation from AmCham HK that the delegation has a quorum. The schedule is subject to change according to the arrangements made by hosting companies/institutions.. **Cancellation Policy: 30% of the fees will be charged for cancellation made on or before Mar 21. No refund for cancellation after Mar 22 or no-show.
Gather at Admiralty MTR Station
Cross-border coach departs to Shenzhen
Visit Shenzhen HarMoniCare Women & Children's Hospital